Resumen de Investigación

Analyzed using Evidence Intelligence™

RT-CGM Enhances Glycemic Control in Prediabetes

Desarrollado con el marco Evidence Intelligence™ de Dediabetes

Última actualización 9 de septiembre de 2026

Key finding

The RT-CGM group demonstrated significantly greater improvements in HbA1c compared to controls at both 1-year (p=0.007) and 2-year (p=0.033) follow-ups.

This study evaluated the impact of real-time continuous glucose monitoring (RT-CGM) on glycemic control in prediabetes. The RT-CGM group showed significant improvements in HbA1c compared to controls.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the impact of real-time continuous glucose monitoring (RT-CGM) on glycemic control in prediabetes. The RT-CGM group showed significant improvements in HbA1c compared to controls.

Clinical relevance

Improving glycemic control in prediabetes is crucial for preventing the progression to type 2 diabetes. This study highlights the potential of RT-CGM as a valuable tool in diabetes health education, suggesting that integrating technology into lifestyle interventions can lead to better health outcomes for at-risk populations.

Keep in mind

The study may have limited generalizability due to specific inclusion criteria. Potential confounding variables were not fully controlled. The sample size and demographic diversity were not specified.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Yuqi M, Sisi D, Wei X, Minfang W, Yeran J. Incorporating Real-Time Continuous Glucose Monitoring into Diabetes Health Education Improves Glycemic Control in Prediabetes. Diabetes, Metabolic Syndrome and Obesity. 2025;18:1939-1948. doi:10.2147/DMSO.S511187

View DOI View on PubMed View on PMC

Efectos Principales

The RT-CGM group demonstrated a significant reduction in HbA1c by -0.49% at 1-year follow-up (p=0.007).

The RT-CGM group also showed a significant reduction in HbA1c at 2-year follow-up (p=0.033).

No significant differences were observed in fasting plasma glucose, BMI, lipid profiles, or uric acid levels between groups.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring and BMI, Fasting Plasma Glucose (FPG), HbA1c, and 2 more.

This study contributes evidence to

Intervention

Continuous glucose monitoring

Outcome

BMI

Evidence topic

Fasting Blood Glucose

Primary intervention

Continuous glucose monitoring

Primary outcomes

BMI
Fasting Plasma Glucose (FPG)
HbA1c

Evidence topics

Fasting Blood Glucose Glycemic Control HbA1c Reduction Weight Loss

Primary intervention

Continuous glucose monitoring

Primary outcomes

BMI Fasting Plasma Glucose (FPG)HbA1c

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

Evidence pairs

Relationships

Evidence topics

contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

Why it is useful

Contributes to 5 evidence relationships
Includes primary outcome data
Linked to 4 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Insulin Delivery Systems and HbA1c

Evidencia relacionada

Relación de evidencia

Insulin Delivery Systems and Fasting Glucose

Guardar evidencia

Relación de evidencia

Insulin Delivery Systems and Body Mass Index

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

BMI

Continuous glucose monitoring → BMI

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 67; Slightly Positive
ConsistencyScore™: 67; generally_consistent

Basado en 3 estudios

Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Continuous glucose monitoring → Fasting Plasma Glucose (FPG)

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 67; Slightly Positive
ConsistencyScore™: 67; generally_consistent

Basado en 3 estudios

Add to Evidence Tracker

HbA1c

Continuous glucose monitoring → HbA1c

Evidence Intelligence™

EvidenceScore™: 85; Strong
ImpactScore™: 81; Positive
ConsistencyScore™: 85; consistent

Basado en 13 estudios

Add to Evidence Tracker

lipid profiles

Continuous glucose monitoring → lipid profiles

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Basado en 1 estudio

Add to Evidence Tracker

Uric Acid

Continuous glucose monitoring → Uric Acid

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Basado en 1 estudio

Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

La Evidencia Sugiere

RT-CGM led to a significant HbA1c reduction of -0.49% at 1 year.
No significant changes were observed in fasting plasma glucose levels.
Control group showed no significant improvement in HbA1c.

A quién se aplica

Adults diagnosed with prediabetes.
Individuals engaged in diabetes health education programs.

Tener en Cuenta

Results may not apply to populations outside the study's demographic.
The long-term effects of RT-CGM on diabetes prevention need further investigation.
The study did not measure all potential confounding factors affecting outcomes.

Entre Líneas

The study may have limited generalizability due to specific inclusion criteria.
Potential confounding variables were not fully controlled.
The sample size and demographic diversity were not specified.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Desarrollado con el marco Evidence Intelligence™ de Dediabetes

This study contributes to evidence on Insulin Delivery Systems and HbA1c, Insulin Delivery Systems and Body Mass Index.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Devices & Technology

Detailed evidence

Insulin Delivery Systems → HbA1c

Devices & Technology

Evidence Intelligence™

EvidenceScore™: 85; Strong
ImpactScore™: 81; Positive
ConsistencyScore™: 85; consistent

Basado en 13 estudios

View evidence

Devices & Technology

Detailed evidence

Insulin Delivery Systems → Body Mass Index

Devices & Technology

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 67; Slightly Positive
ConsistencyScore™: 67; generally_consistent

Basado en 3 estudios

View evidence

Devices & Technology

Detailed evidence

Insulin Delivery Systems → lipid profiles

Devices & Technology

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Basado en 1 estudio

View evidence

Incluido en estas colecciones de evidencia

Curated evidence collections and hubs this study is part of.

HbA1c Evidence Hub

All studies measuring HbA1c

13 studies

outcome_hub

Measures HbA1c as a key outcome.

Insulin Delivery Systems Evidence Hub

All studies on Insulin Delivery Systems

13 studies

intervention_hub

Contributes to Insulin Delivery Systems evidence base.

Body Mass Index Evidence Hub

All studies measuring Body Mass Index

3 studies

outcome_hub

Measures Body Mass Index as a key outcome.

lipid profiles Evidence Hub

All studies measuring lipid profiles

1 studies

outcome_hub

Measures lipid profiles as a key outcome.

Recent Diabetes Research

Latest published studies

recency_collection

Published within the last 2 years.

Explora más en Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

All studies on Continuous glucose monitoring and HbA1c

Intervention: Continuous glucose monitoringOutcome: HbA1c

13 results

All studies on Continuous glucose monitoring and BMI

Intervention: Continuous glucose monitoringOutcome: BMI

3 results

All studies on Continuous glucose monitoring

Intervention: Continuous glucose monitoring

13 results

All studies measuring HbA1c

Outcome: HbA1c

13 results

All studies measuring BMI

Outcome: BMI

3 results

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Delivery Systems lower HbA1c?

Strong Evidence

Insulin Delivery Systems appears to lower HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.5 | moderate positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on 21 supporting studies with consistent results and a positive effect signal.

View Full Evidence

Does Insulin Delivery Systems improve fasting glucose?

Strong Evidence

Insulin Delivery Systems may improve fasting glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

View Full Evidence

Does Insulin Delivery Systems affect body mass index?

Strong Evidence

Insulin Delivery Systems may affect body mass index.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
BMI
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on 3 supporting studies with generally consistent results and a positive effect signal.

View Full Evidence

Does Insulin Delivery Systems improve uric acid levels?

Emerging Evidence

Current evidence does not show a clear benefit of Insulin Delivery Systems for uric acid levels.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Uric Acid
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.

View Full Evidence

Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Fasting Blood Glucose Evidence Hub Glycemic Control Evidence Hub HbA1c Reduction Evidence Hub Weight Loss Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Continuous glucose monitoring and HbA1c All studies on Continuous glucose monitoring and BMI All studies on Continuous glucose monitoring and Fasting Plasma Glucose (FPG)All studies on Continuous glucose monitoring and Uric Acid

Related research

Read related research summaries.

Caloric restriction improves glycemic control Real-Time CGM Improves Glycemic Control in Type 2 Diabetes Bariatric surgery improves glucose homeostasis in type 2 diabetes.RT-CGM improves glucose control in adults with T2D Dietary supplements may lower diabetes risk in prediabetes

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.